8. Apple 2023 Forecasting Template(1)

Total non-current liabilities 149,675 Total liabilities 279,610 Commitments and contingencies n/a Shareholders' equity: Common stock and additional paid-in capital 71,783 Retained earnings 457 Accumulated other comprehensive income/(loss) (11,856) Total shareholders' equity 58,447 Total liabilities and shareholders' equity 337,941 STATEMENT OF CASH FLOWS Cash, cash equivalents and restricted cash, beginning balances 5,550 Operating activities: Net income 22,493 Adjustments to reconcile net income to cash generated by operating activities: Depreciation and amortization 3,004 Share-based compensation expense 2,678 Deferred income tax benefit n/a Other (350) Changes in operating assets and liabilities: Accounts receivable, net 1,341 Inventories (576) Vendor non-trade receivables 2,584 Other current and non-current assets (1,284) Accounts payable (3,017) Deferred revenue 8,185 Other current and non-current liabilities 1,128 Cash generated by operating activities 28,100

Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023 Projected using percentage change from Q2 to Q3 of 2023

12 Months Ended Sep. 24, 2022 Sep. 25, 2021 Sep. 26, 2020 Net sales $ 394,328 $ 365,817 $ 274,515 Cost of sales 223,546 212,981 169,559 Gross margin 170,782 152,836 104,956 Operating expenses: Research and development 26,251 21,914 18,752 Selling, general and administrative 25,094 21,973 19,916 Total operating expenses 51,345 43,887 38,668 Operating income 119,437 108,949 66,288 Other income/(expense), net (334) 258 803 Income before provision for income taxes 119,103 109,207 67,091 Provision for income taxes 19,300 14,527 9,680 Net income $ 99,803 $ 94,680 $ 57,411 Earnings per share: Basic (in dollars per share) $ 6.15 $ 5.67 $ 3.31 Diluted (in dollars per share) $ 6.11 $ 5.61 $ 3.28 Shares used in computing earnings per share: Basic (in shares) 16,215,963 16,701,272 17,352,119 Diluted (in shares) 16,325,819 16,864,919 17,528,214 Products Net sales $ 316,199 $ 297,392 $ 220,747 Cost of sales 201,471 192,266 151,286 Services Net sales 78,129 68,425 53,768 Cost of sales $ 22,075 $ 20,715 $ 18,273 Dividends and dividend equivalents declared per share CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions

Total shareholders’ equity 50,672 63,090 Total liabilities and shareholders’ equity $ 352,755 $ 351,002

12 Months Ended 3 month Sep. 24, 2022 Sep. 25, 2021 Sep. 26, 2020 Jul. 01, 2023 Statement of Cash Flows [Abstract] Cash, cash equivalents and restricted cash, beginning balances $ 35,929 $ 39,789 $ 50,224 8,326 Operating activities: Net income 99,803 94,680 57,411 24,680 Depreciation and amortization 11,104 11,284 11,056 2,955 Share-based compensation expense 9,038 7,906 6,829 2,736 Deferred income tax expense/(benefit) 895 (4,774) (215) Other 111 (147) (97) (550) Changes in operating assets and liabilities: Accounts receivable, net (1,823) (10,125) 6,917 2,536 Inventories 1,484 (2,642) (127) (857) Vendor non-trade receivables (7,520) (3,903) 1,553 4,370 Other current and non-current assets (6,499) (8,042) (9,588) (1,621) Accounts payable 9,448 12,326 (4,062) (5,597) Deferred revenue 478 1,676 2,081 Other current and non-current liabilities 5,632 5,799 8,916 995 Cash generated by operating activities 122,151 104,038 80,674 29,648 Investing activities: Purchases of marketable securities (76,923) (109,558) (114,938) (6,985) Proceeds from maturities of marketable securities 29,917 59,023 69,918 9,286 Proceeds from sales of marketable securities 37,446 47,460 50,473 1,320 Payments for acquisition of property, plant and equipment (10,708) (11,085) (7,309) (2,932) Payments made in connection with business acquisitions, net (306) (33) (1,524) Other (1,780) (352) (909) (251) Cash used in investing activities (22,354) (14,545) (4,289) 437 Financing activities: (6,223) (6,556) (3,634) (1,706) Payments for dividends and dividend equivalents (14,841) (14,467) (14,081) (3,756) Repurchases of common stock (89,402) (85,971) (72,358) (18,849) CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions Adjustments to reconcile net income to cash generated by operating activities: Payments for taxes related to net share settlement of equity awards

(1,826) (3,375) (3,980) (228) (30,644) 1,076 13,565 2,447 937